BRISTOL-MYERS SQUIBB COMPANY Increase (Decrease) in Accounts Payable
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Increase (Decrease) in Accounts Payable of $380.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$29.00M, a 323.08% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $409.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$90.00M, a 117.41% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $160.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for fiscal 2025 was -$2.00M, a 101.09% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for fiscal 2024 was $184.00M, a 7.07% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for fiscal 2023 was $198.00M, a 81.65% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in accounts payable for fiscal 2022 was $109.00M, a 55.51% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $380.00M 10-Q · filed 2026-07-30 | $290.00M derived: sum of 3 quarters · filed 2026-07-30 | $450.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $409.00M 10-Q · filed 2026-04-30 | $319.00M derived: sum of 2 quarters · filed 2026-04-30 | $479.00M derived: sum of 3 quarters · filed 2026-04-30 | $492.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $70.00M derived: sum of 2 quarters · filed 2026-02-11 | $83.00M derived: sum of 3 quarters · filed 2026-07-30 | -$2.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $160.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $173.00M derived: sum of 2 quarters · filed 2026-07-30 | $88.00M 10-Q · filed 2025-10-30 | $605.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$72.00M 10-Q · filed 2026-07-30 | $445.00M derived: sum of 3 quarters · filed 2026-07-30 | $71.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$85.00M 10-Q · filed 2026-04-30 | $432.00M derived: sum of 2 quarters · filed 2026-04-30 | $58.00M derived: sum of 3 quarters · filed 2026-04-30 | -$201.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $517.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $143.00M derived: sum of 2 quarters · filed 2026-02-11 | -$116.00M derived: sum of 3 quarters · filed 2026-02-11 | $184.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$374.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$633.00M derived: sum of 2 quarters · filed 2025-10-30 | -$333.00M 10-Q · filed 2025-10-30 | $111.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$259.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $41.00M 10-Q · filed 2025-07-31 | $485.00M derived: sum of 3 quarters · filed 2026-02-11 | $217.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $300.00M 10-Q · filed 2025-04-24 | $744.00M derived: sum of 2 quarters · filed 2026-02-11 | $476.00M derived: sum of 3 quarters · filed 2026-02-11 | $311.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $444.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $176.00M derived: sum of 2 quarters · filed 2026-02-11 | $11.00M derived: sum of 3 quarters · filed 2026-02-11 | $198.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | -$268.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$433.00M derived: sum of 2 quarters · filed 2024-10-31 | -$246.00M 10-Q · filed 2024-10-31 | $159.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$165.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $22.00M 10-Q · filed 2024-07-26 | $427.00M derived: sum of 3 quarters · filed 2025-02-12 | $127.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $187.00M 10-Q · filed 2024-04-25 | $592.00M derived: sum of 2 quarters · filed 2025-02-12 | $292.00M derived: sum of 3 quarters · filed 2025-02-12 | $273.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $405.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $105.00M derived: sum of 2 quarters · filed 2025-02-12 | $86.00M derived: sum of 3 quarters · filed 2025-02-12 | $109.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$300.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$319.00M derived: sum of 2 quarters · filed 2023-10-26 | -$296.00M 10-Q · filed 2023-10-26 | -$70.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | -$19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $4.00M 10-Q · filed 2023-07-27 | $230.00M derived: sum of 3 quarters · filed 2024-02-13 | $91.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $23.00M 10-Q · filed 2023-04-27 | $249.00M derived: sum of 2 quarters · filed 2024-02-13 | $110.00M derived: sum of 3 quarters · filed 2024-02-13 | -$35.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $226.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $87.00M derived: sum of 2 quarters · filed 2024-02-13 | -$58.00M derived: sum of 3 quarters · filed 2024-02-13 | $245.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$139.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | -$284.00M derived: sum of 2 quarters · filed 2022-10-26 | $19.00M 10-Q · filed 2022-10-26 | $151.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$145.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $158.00M 10-Q · filed 2022-07-27 | $290.00M derived: sum of 3 quarters · filed 2023-02-14 | -$134.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $303.00M 10-Q · filed 2022-04-29 | $435.00M derived: sum of 2 quarters · filed 2023-02-14 | $11.00M derived: sum of 3 quarters · filed 2023-02-14 | -$212.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $132.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$292.00M derived: sum of 2 quarters · filed 2023-02-14 | -$515.00M derived: sum of 3 quarters · filed 2023-02-14 | $188.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$424.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$647.00M derived: sum of 2 quarters · filed 2021-10-27 | $56.00M 10-Q · filed 2021-10-27 | $237.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | -$223.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $480.00M 10-Q · filed 2021-07-28 | $661.00M derived: sum of 3 quarters · filed 2022-02-09 | $553.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $703.00M 10-Q · filed 2021-04-29 | $884.00M derived: sum of 2 quarters · filed 2022-02-09 | $776.00M derived: sum of 3 quarters · filed 2022-02-09 | $796.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $181.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $73.00M derived: sum of 2 quarters · filed 2022-02-09 | $93.00M derived: sum of 3 quarters · filed 2022-02-09 | $229.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | -$108.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$88.00M derived: sum of 2 quarters · filed 2020-11-05 | $48.00M 10-Q · filed 2020-11-05 | $175.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $156.00M 10-Q · filed 2020-08-06 | $283.00M derived: sum of 3 quarters · filed 2021-02-10 | $198.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $136.00M 10-Q · filed 2020-05-07 | $263.00M derived: sum of 2 quarters · filed 2021-02-10 | $178.00M derived: sum of 3 quarters · filed 2021-02-10 | $318.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $42.00M derived: sum of 2 quarters · filed 2021-02-10 | $182.00M derived: sum of 3 quarters · filed 2021-02-10 | -$59.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | -$85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $55.00M derived: sum of 2 quarters · filed 2019-10-31 | -$186.00M 10-Q · filed 2019-10-31 | $71.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $140.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$101.00M 10-Q · filed 2019-07-25 | $156.00M derived: sum of 3 quarters · filed 2020-02-24 | $304.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | -$241.00M 10-Q · filed 2019-04-25 | $16.00M derived: sum of 2 quarters · filed 2020-02-24 | $164.00M derived: sum of 3 quarters · filed 2020-02-24 | $193.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $257.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $405.00M derived: sum of 2 quarters · filed 2020-02-24 | $434.00M derived: sum of 3 quarters · filed 2020-02-24 | $320.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | $148.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $177.00M derived: sum of 2 quarters · filed 2018-10-25 | $63.00M 10-Q · filed 2018-10-25 | $309.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$85.00M 10-Q · filed 2018-07-26 | $161.00M derived: sum of 3 quarters · filed 2019-02-25 | $55.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$114.00M 10-Q · filed 2018-04-26 | $132.00M derived: sum of 2 quarters · filed 2019-02-25 | $26.00M derived: sum of 3 quarters · filed 2019-02-25 | $67.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $246.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $140.00M derived: sum of 2 quarters · filed 2019-02-25 | $181.00M derived: sum of 3 quarters · filed 2019-02-25 | $104.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | -$106.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$65.00M derived: sum of 2 quarters · filed 2017-10-26 | -$142.00M 10-Q · filed 2017-10-26 | $157.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$36.00M 10-Q · filed 2017-07-27 | $263.00M derived: sum of 3 quarters · filed 2018-02-13 | -$337.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | -$77.00M 10-Q · filed 2017-04-27 | $222.00M derived: sum of 2 quarters · filed 2018-02-13 | -$378.00M derived: sum of 3 quarters · filed 2018-02-13 | -$913.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $299.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$301.00M derived: sum of 2 quarters · filed 2018-02-13 | -$836.00M derived: sum of 3 quarters · filed 2018-02-13 | -$919.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | -$600.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | -$1.14B derived: sum of 2 quarters · filed 2016-10-27 | -$1.22B 10-Q · filed 2016-10-27 | -$1.32B derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | -$535.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$618.00M 10-Q · filed 2016-07-28 | -$725.00M derived: sum of 3 quarters · filed 2017-02-21 | -$550.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | -$83.00M 10-Q · filed 2016-04-28 | -$190.00M derived: sum of 2 quarters · filed 2017-02-21 | -$15.00M derived: sum of 3 quarters · filed 2017-02-21 | -$115.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | -$107.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $68.00M derived: sum of 2 quarters · filed 2017-02-21 | -$32.00M derived: sum of 3 quarters · filed 2017-02-21 | -$44.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $175.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $75.00M derived: sum of 2 quarters · filed 2015-10-27 | $63.00M 10-Q · filed 2015-10-27 | $174.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | -$100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | -$112.00M 10-Q · filed 2015-07-23 | -$1.00M derived: sum of 3 quarters · filed 2016-02-12 | $97.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$12.00M 10-Q · filed 2015-04-28 | $99.00M derived: sum of 2 quarters · filed 2016-02-12 | $197.00M derived: sum of 3 quarters · filed 2016-02-12 | $453.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $111.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $209.00M derived: sum of 2 quarters · filed 2016-02-12 | $465.00M derived: sum of 3 quarters · filed 2016-02-12 | $412.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $98.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $354.00M derived: sum of 2 quarters · filed 2014-10-24 | $301.00M 10-Q · filed 2014-10-24 | $390.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $256.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $203.00M 10-Q · filed 2014-07-24 | $292.00M derived: sum of 3 quarters · filed 2015-02-13 | $193.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | -$53.00M 10-Q · filed 2014-04-29 | $36.00M derived: sum of 2 quarters · filed 2015-02-13 | -$63.00M derived: sum of 3 quarters · filed 2015-02-13 | -$317.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$10.00M derived: sum of 2 quarters · filed 2015-02-13 | -$264.00M derived: sum of 3 quarters · filed 2015-02-13 | -$232.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$99.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$353.00M derived: sum of 2 quarters · filed 2013-10-23 | -$321.00M 10-Q · filed 2013-10-23 | -$37.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | -$254.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$222.00M 10-Q · filed 2013-07-25 | $62.00M derived: sum of 3 quarters · filed 2014-02-14 | -$41.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $32.00M 10-Q · filed 2013-04-25 | $316.00M derived: sum of 2 quarters · filed 2014-02-14 | $213.00M derived: sum of 3 quarters · filed 2014-02-14 | $563.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $284.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $181.00M derived: sum of 2 quarters · filed 2014-02-14 | $531.00M derived: sum of 3 quarters · filed 2014-02-14 | $593.00M 10-K · filed 2014-02-14 |
| 2011-09-30 | -$103.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $247.00M derived: sum of 2 quarters · filed 2012-10-24 | $309.00M 10-Q · filed 2012-10-24 | $547.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $350.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $412.00M 10-Q · filed 2012-07-25 | $650.00M derived: sum of 3 quarters · filed 2013-02-15 | $673.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $62.00M 10-Q · filed 2012-04-26 | $300.00M derived: sum of 2 quarters · filed 2013-02-15 | $323.00M derived: sum of 3 quarters · filed 2013-02-15 | $258.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $238.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $261.00M derived: sum of 2 quarters · filed 2013-02-15 | $196.00M derived: sum of 3 quarters · filed 2013-02-15 | $315.00M 10-K · filed 2013-02-15 |
| 2010-09-30 | $23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$42.00M derived: sum of 2 quarters · filed 2011-10-27 | $77.00M 10-Q · filed 2011-10-27 | $321.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | -$65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $54.00M 10-Q · filed 2011-07-28 | $298.00M derived: sum of 3 quarters · filed 2012-02-17 | $260.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $119.00M 10-Q · filed 2011-04-28 | $363.00M derived: sum of 2 quarters · filed 2012-02-17 | $325.00M derived: sum of 3 quarters · filed 2012-02-17 | $385.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $244.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $206.00M derived: sum of 2 quarters · filed 2012-02-17 | $266.00M derived: sum of 3 quarters · filed 2012-02-17 | $472.00M 10-K · filed 2012-02-17 |
| 2009-09-30 | -$38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $22.00M derived: sum of 2 quarters · filed 2010-10-26 | $228.00M 10-Q · filed 2010-10-26 | $335.00M derived: sum of 4 quarters · filed 2011-02-18 |
| 2009-06-30 | $60.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | $266.00M 10-Q · filed 2010-07-22 | $373.00M derived: sum of 3 quarters · filed 2011-02-18 | $214.00M derived: sum of 4 quarters · filed 2011-02-18 |
| 2009-03-31 | $206.00M 10-Q · filed 2010-04-29 | $313.00M derived: sum of 2 quarters · filed 2011-02-18 | $154.00M derived: sum of 3 quarters · filed 2011-02-18 | |
| 2008-12-31 | $107.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$52.00M derived: sum of 2 quarters · filed 2011-02-18 | $253.00M 10-K · filed 2011-02-18 | |
| 2008-09-30 | -$159.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $146.00M 10-Q · filed 2009-10-22 | ||
| 2008-06-30 | $305.00M 10-Q · filed 2009-07-23 | |||
| 2007-12-31 | $141.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |